The Journal of Pediatrics
Volume 149, Issue 6 , Pages 781-787, December 2006

Exposure to marijuana during pregnancy alters neurobehavior in the early neonatal period

Division of Neonatal Medicine, Division of Biostatistics, and Research Unit on Alcohol and Drugs, Federal University of São Paulo, São Paulo, Brazil

Received 5 December 2005; received in revised form 25 May 2006; accepted 19 August 2006.

Objective

To assess the neurobehavior of full-term neonates of adolescent mothers exposed to marijuana during pregnancy.

Study design

This prospective cross-sectional study included full-term infants within 24 to 72 hours of life born to adolescent mothers at a single center in Brazil. Data on sociodemographic and obstetrical and neonatal characteristics were collected. The mothers underwent the Composite International Diagnostic Interview, and the infants were assessed with the Neonatal Intensive Care Unit Network Neurobehavioral Scale (NNNS). Maternal hair and neonatal meconium were analyzed. Neonates exposed in utero to tobacco, alcohol, cocaine, and/or any other drugs except marijuana were excluded.

Results

Of 3685 infants born in the study hospital, 928 (25%) were born to adolescent mothers. Of these, 561 infants met the inclusion criteria and were studied. Marijuana exposure was detected in 26 infants (4.6%). Infants exposed (E) or not exposed (NE) to marijuana differed in the following NNNS variables: arousal (E, 4.05 ± 1.19 vs NE, 3.68 ± 0.70), regulation (E, 5.75 ± 0.62 vs NE, 6.04 ± 0.72), and excitability (E, 3.27 ± 1.40 vs NE, 2.40 ± 1.57). After controlling for confounding variables, the effect of marijuana exposure on these scores remained significant.

Conclusions

Marijuana exposure during pregnancy alters the neurobehavioral performance of term newborn infants of adolescent mothers.

Abbreviations: CIDI, Composite International Diagnostic Interview, NNNS, Neonatal Intensive Care Unit Network Neurobehavioral Scale

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Fully funded as a thematic project by the State of São Paulo Research Support Foundation (grant 2000/10293-5).

 None of the authors has any conflict of interest to declare.

PII: S0022-3476(06)00799-2

doi:10.1016/j.jpeds.2006.08.046

Refers to article:

  • Midodrine for the treatment of vasovagal syncope (simple FAINT)

    Julian M. Stewart
    The Journal of Pediatrics December 2006 (Vol. 149, Issue 6, Pages 740-742)

The Journal of Pediatrics
Volume 149, Issue 6 , Pages 781-787, December 2006